Outside-in signaling mechanisms of platelet integrin alpha-IIb-beta3

血小板整合素α-IIb-β3由外而内的信号传导机制

基本信息

  • 批准号:
    9241429
  • 负责人:
  • 金额:
    $ 40.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-12-15 至 2020-03-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The platelet adhesion receptor, integrin αIIbβ3, plays a critical physiological role in hemostasis and also a critical pathological role in thrombosis and in the development of thrombotic diseases such as heart attack and stroke. The integrin antagonists are effective anti-thrombotics but also have significant adverse effect of hemorrhage, which can be life-threatening. Thus, it is important to develop a new generation of anti-thrombotics that minimally cause adverse effect of bleeding. Integrin αIIbβ3 not only mediates platelet adhesion and aggregation but also transmits signals bidirectionally: Agonist-induced intracellular signals from within platelets activate the extracellular ligand binding function of integrin αIIbβ3 ("inside-out" signaling). The binding of extracellular ligand to αIIβ3 then induces "outside-in" signals, which elicit cellular responses such as platelet spreading, granule secretion, and platelet-dependent clot retraction. The "outside-in signaling" response is critical in amplifying and stabilizing thrombi, which is critically important in occlusive thromboss. During the current funding period, we have shown that the G protein subunit, Gα13, directly interacts with a highly conserved ExE motif in the cytoplasmic domain of several integrin β subunits between talin binding sites, and "time-share" the binding region with talin in opposing waves. Talin binding occurs during inside-out signaling and late phase outside-in signaling, whereas the Gα13 binding occurs during early phase outside-in signaling. We further show that Gα13 is selectively important in the early phase outside-in signaling leading to platelet spreading and amplification of platelet thrombus formation. Importantly, we have developed selective inhibitors of Gα13-integrin interaction that potently inhibited integrin outside-in signaling and arterial thrombosis without causing adverse effect of bleeding. Based on these data, we propose the overall hypothesis that the opposing waves of talin and Gα13 binding to integrin cytoplasmic domain switch the direction of integrin signaling and also control outcomes of integrin outside-in signaling. To test this hypothesis, we propose the following specific aims: (1) To investigate the switch between talin and Gα13 binding to β3 during integrin signaling and its regulatory mechanisms. (2)To further investigate the roles of Gα13-integrin interaction in mediating integrin outside-in signaling, amplification of platelet activation, and thrombosis. These studies will facilitate the development of new generations of anti-thrombotic drugs for treating thrombosis without causing excessive bleeding.
 描述(由申请人证明):血小板粘附受体,整联蛋白αIIBβ3在血栓形成和血栓形成中起关键的病理作用,在血栓形成和血栓形成中起关键的生理作用 在血栓形成的探针和中风的发展中,整联蛋白拮抗剂有效,但也具有重要的出血,这可能是生命的,因此很重要。流血不仅是双向的:血小板内的激动剂 - 触觉细胞激活细胞外配体结合蛋白αTegrinIBβ3(“内部 - 外出”信号)( ,颗粒的“外部符号”的呼吸对于放大和稳定稳定的血栓性血栓血栓血栓至关重,安宁位点的时间共享”与塔林在相对波中的结合。EGα13结合发生在早期阶段外部信号传导中。我们进一步表明,Gα13是在早期阶段 - 入置信号传导中有选择性的图像。Gα13的选择性抑制剂。 - 基于这些数据,我们提出了整体假设,从而抑制整联蛋白的外部信号传导和动脉血栓形成。整合素的信号传导。 。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Xiaoping Du其他文献

Xiaoping Du的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Xiaoping Du', 18)}}的其他基金

Mechanisms of integrin signaling and a new anti-platelet/anti-inflammatory approach
整合素信号传导机制和新的抗血小板/抗炎方法
  • 批准号:
    9894367
  • 财政年份:
    2020
  • 资助金额:
    $ 40.35万
  • 项目类别:
Mechanisms of integrin signaling and a new anti-platelet/anti-inflammatory approach
整合素信号传导机制和新的抗血小板/抗炎方法
  • 批准号:
    10434683
  • 财政年份:
    2020
  • 资助金额:
    $ 40.35万
  • 项目类别:
Mechanisms of integrin signaling and a new anti-platelet/anti-inflammatory approach
整合素信号传导机制和新的抗血小板/抗炎方法
  • 批准号:
    10772297
  • 财政年份:
    2020
  • 资助金额:
    $ 40.35万
  • 项目类别:
Mechanisms of integrin signaling and a new anti-platelet/anti-inflammatory approach
整合素信号传导机制和新的抗血小板/抗炎方法
  • 批准号:
    10612047
  • 财政年份:
    2020
  • 资助金额:
    $ 40.35万
  • 项目类别:
The cGMP-dependent protein kinase pathway in platelets
血小板中 cGMP 依赖性蛋白激酶途径
  • 批准号:
    7819163
  • 财政年份:
    2009
  • 资助金额:
    $ 40.35万
  • 项目类别:
Outside-in signaling mechanisms of platelet integrin alpha-llb-beta3
血小板整合素α-IIb-β3由外而内的信号传导机制
  • 批准号:
    8309906
  • 财政年份:
    2006
  • 资助金额:
    $ 40.35万
  • 项目类别:
Calpain and beta3 cytoplasmic domain in platelet integrin signaling
血小板整合素信号传导中的钙蛋白酶和 β3 胞质结构域
  • 批准号:
    7213806
  • 财政年份:
    2006
  • 资助金额:
    $ 40.35万
  • 项目类别:
Outside-in signaling mechanisms of platelet integrin alpha-IIb-beta3
血小板整合素α-IIb-β3由外而内的信号传导机制
  • 批准号:
    9120601
  • 财政年份:
    2006
  • 资助金额:
    $ 40.35万
  • 项目类别:
Outside-in signaling mechanisms of platelet integrin alpha-llb-beta3
血小板整合素α-IIb-β3由外而内的信号传导机制
  • 批准号:
    8186790
  • 财政年份:
    2006
  • 资助金额:
    $ 40.35万
  • 项目类别:
Outside-in signaling mechanisms of platelet integrin alpha-llb-beta3
血小板整合素α-IIb-β3由外而内的信号传导机制
  • 批准号:
    8528688
  • 财政年份:
    2006
  • 资助金额:
    $ 40.35万
  • 项目类别:

相似国自然基金

聚电解质络合作用调控的高初黏性大豆蛋白粘合剂构建及增强机制研究
  • 批准号:
    52303059
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
氮杂环丙烷基聚多硫化物可逆粘合剂的分子设计与制备
  • 批准号:
    22378080
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
仿深共晶溶剂小分子类低温粘合剂的设计制备及粘附机制研究
  • 批准号:
    22308299
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
多酚功能化壳聚糖基组织粘合剂构建及其能量耗散机制探究
  • 批准号:
    82302389
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于短肽诱导蚕丝蛋白组装的可控粘附生物粘合剂的制备及粘附性能研究
  • 批准号:
    52303272
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Structure-Function Studies of Aquaporin 0 in Lens Development and Physiology
水通道蛋白 0 在晶状体发育和生理学中的结构功能研究
  • 批准号:
    10334493
  • 财政年份:
    2021
  • 资助金额:
    $ 40.35万
  • 项目类别:
Structure-Function Studies of Aquaporin 0 in Lens Development and Physiology
水通道蛋白 0 在晶状体发育和生理学中的结构功能研究
  • 批准号:
    10547773
  • 财政年份:
    2021
  • 资助金额:
    $ 40.35万
  • 项目类别:
Nature-inspired Aqueous Biodegradable Adhesives for Abdominoplasty
用于腹部整形术的受自然启发的水性可生物降解粘合剂
  • 批准号:
    10080783
  • 财政年份:
    2020
  • 资助金额:
    $ 40.35万
  • 项目类别:
Conformational regulation in integrin bidirectional transmembrane signaling
整合素双向跨膜信号传导的构象调控
  • 批准号:
    9130426
  • 财政年份:
    2015
  • 资助金额:
    $ 40.35万
  • 项目类别:
Small Molecule Inhibition of Pilus Biogenesis by Pathogenic Bacteria
病原菌对菌毛生物发生的小分子抑制
  • 批准号:
    9185942
  • 财政年份:
    2015
  • 资助金额:
    $ 40.35万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了